Hydroxyzine Clinical Applications and Safety Considerations

Primary Clinical Indications

Hydroxyzine is effective for managing pruritus associated with allergic conditions, urticaria, and dermatological reactions, with dosing typically ranging from 10-50 mg, and can be used as a sedating antihistamine at night in combination with a non-sedating antihistamine during the day for patients with urticaria who have sleep disturbances 1, 2, 3
The British Journal of Dermatology recommends hydroxyzine for anxiety management, with dosing ranging from 10-50 mg, though it is not typically considered a first-line treatment due to limited high-quality evidence 1, 2

The Journal of Allergy and Clinical Immunology notes that significant sedative effects of hydroxyzine can impair driving ability, work performance, and cognitive function, and is associated with increased risk of motor vehicle accidents, with drivers in fatal accidents being 1.5 times more likely to be taking first-generation antihistamines 4, 5
Performance impairment can occur without subjective awareness of drowsiness, and impaired driving performance with hydroxyzine worsens with concurrent activities like cell phone use 4, 5

The British Journal of Dermatology guidelines state that hydroxyzine is contraindicated during early pregnancy, and dose should be halved in moderate renal impairment, and avoided in severe renal impairment 1, 2
The Journal of Allergy and Clinical Immunology recommends that elderly patients start with lower doses and be monitored closely, as they are more sensitive to psychomotor impairment and at increased risk for falls and anticholinergic effects 4, 5

The British Journal of Dermatology recommends dosing of 10-50 mg per dose for anxiety, and 10-50 mg, often given at night, for pruritus/urticaria 1, 2
Dose should be reduced in elderly patients and those with moderate renal impairment 1, 2

The Journal of Allergy and Clinical Immunology notes that second-generation antihistamines are generally preferred over hydroxyzine for daytime use due to their reduced sedative effects, and the AM/PM dosing regimen may still result in daytime drowsiness due to hydroxyzine's prolonged half-life 4, 5
The National Comprehensive Cancer Network recommends hydroxyzine as an adjunctive treatment for opioid-induced pruritus and nausea 6
The American Academy of Pediatrics recommends hydroxyzine for chemical restraint in agitated patients, particularly in children and adolescents 7

The British Journal of Dermatology guidelines support combining loratadine with hydroxyzine for conditions like urticaria or allergic rhinitis, particularly when using loratadine during the day and hydroxyzine at night 8, 9

The British Journal of Dermatology guidelines recommend adding a sedating antihistamine like hydroxyzine at night to a non-sedating antihistamine during the day for patients with urticaria who have sleep disturbances 8, 9
Loratadine provides daytime coverage without sedation or performance impairment at recommended doses 10
Hydroxyzine at bedtime addresses nighttime symptoms and helps patients sleep better 8, 9

Hydroxyzine dose should be halved in moderate renal impairment, and loratadine should be used with caution in severe renal impairment 11, 9
Hydroxyzine should be avoided in severe liver disease because its sedating effect is inappropriate 11, 9
Hydroxyzine is specifically contraindicated during early pregnancy, while loratadine is FDA Pregnancy Category B 9
Older adults are more sensitive to psychomotor impairment from hydroxyzine and at increased risk for falls, fractures, and anticholinergic effects 10

For patients requiring combination therapy, loratadine 10 mg once daily in the morning and hydroxyzine 10-50 mg at bedtime can be used, with hydroxyzine dose adjusted based on tolerability and renal function 8, 9, 11

The combination of loratadine and hydroxyzine is most useful when sleep disturbance is a significant problem, not primarily for enhanced antihistamine effect 8, 9
Consider alternative strategies before adding hydroxyzine if sedation is problematic 11, 8

Hydroxyzine is approved for anxiolytic therapy in children in both Europe and the United States and is marketed in tablet and syrup formulations with few contraindications. 12

Co‑administration of hydroxyzine with other anxiolytic agents (e.g., benzodiazepines) is contraindicated because of the heightened risk of additive central nervous system depression and related adverse events. 12

Sedating antihistamines such as hydroxyzine should not be prescribed for pruritus in elderly patients due to an increased likelihood of falls, fractures, and anticholinergic side‑effects. 13